This glossary is designed to help researchers, compliance teams, and lab operators navigate the specialized language used across research chemicals, analytical chemistry, pharmacology, and regulatory contexts. It is educational and informational, not legal or medical advice, and does not endorse human consumption or clinical use.

Core chemistry and analytical methods

General chemistry

• Compound: A substance formed when two or more chemical elements are chemically bonded in fixed proportions.
• Functional group: A specific atom or group of atoms responsible for characteristic chemical reactions of a molecule.
• Isomer: Molecules with the same molecular formula but different arrangements of atoms or bonding.
• Stereochemistry: The three-dimensional arrangement of atoms in molecules and its impact on properties.
• Chirality: A property where a molecule cannot be superimposed on its mirror image; often produces enantiomers.
• Enantiomer: One of a pair of chiral molecules that are non-superimposable mirror images.
• Diastereomer: Stereoisomers that are not mirror images and often have different physical properties.
• Racemate (racemic mixture): A 50:50 mixture of two enantiomers, typically denoted as (±).
• Salt form: An ionic form of a compound (e.g., hydrochloride, fumarate) used to modify solubility and stability.
• Prodrug: An inactive or less active compound that is metabolized into an active drug form in vivo (for research context: studied mechanistically, not clinically).
• Analog: A compound structurally related to another, often modified by substituting functional groups or side chains.
• Homolog: A member of a chemical series differing by a repeating unit (e.g., –CH₂–) from adjacent members.
• Polymorph: Different crystalline forms of the same compound with distinct physical properties.
• Tautomer: Isomeric forms that interconvert via proton transfer and double bond shifts (e.g., keto–enol).

Purity, identity, and quality control

• CAS number: A unique numerical identifier assigned to chemicals by the Chemical Abstracts Service.
• Certificate of analysis (CoA): A document summarizing test results, methods, and specifications for a lot/batch.
• Batch (lot): A defined quantity produced under uniform conditions; traceable by lot number.
• Reference standard: A well-characterized material used to calibrate instruments or validate methods.
• Impurity profile: Qualitative and quantitative description of detectable impurities in a sample.
• Residual solvents: Organic solvents remaining after synthesis; monitored per internal specifications.
• LOD (limit of detection): The lowest analyte concentration discernible from background noise.
• LOQ (limit of quantitation): The lowest concentration measurable with acceptable accuracy and precision.
• Precision: Closeness of repeated measurements to each other under specified conditions.
• Accuracy: Closeness of measurements to the true value of the analyte.
• Calibration curve: A plot of instrument response versus known concentrations to derive analyte amounts.
• Matrix effect: Influence of sample components on the measurement of the analyte.

Analytical techniques

• GC–MS (gas chromatography–mass spectrometry): Separates volatile compounds and identifies them by mass spectra.
• LC–MS/MS (liquid chromatography–tandem mass spectrometry): Separates nonvolatile compounds and detects fragments for specificity and sensitivity.
• HPLC (high-performance liquid chromatography): Pressure-driven liquid chromatography for separating and quantifying compounds.
• UHPLC (ultra-high-performance liquid chromatography): Higher pressure HPLC allowing faster, higher-resolution separations.
• NMR (nuclear magnetic resonance): Spectroscopy that provides structural information from nuclear spin environments.
• FTIR (Fourier-transform infrared): Measures infrared absorption to identify functional groups and bonds.
• UV–Vis spectroscopy: Uses ultraviolet/visible light absorption to quantify or characterize compounds.
• MS (mass spectrometry): Determines mass-to-charge ratios to identify and quantify molecules.
• Thin-layer chromatography (TLC): Rapid screening method for separations on coated plates.
• XRD (X-ray diffraction): Determines crystal structure and polymorphic forms.
• Elemental analysis (CHN): Measures carbon, hydrogen, nitrogen content to confirm empirical formula.
• Karl Fischer titration: Quantifies water content (moisture) in samples.
• Specific rotation: Optical rotation measurement used to characterize chiral purity.

Pharmacology and toxicology concepts

Mechanism and interaction

• Agonist: Binds to a receptor and produces a biological response.
• Partial agonist: Produces a response but less than a full agonist even at full receptor occupancy.
• Antagonist: Binds to a receptor and blocks or reduces the effect of agonists.
• Inverse agonist: Reduces constitutive receptor activity below basal levels.
• Allosteric modulator: Binds to non-active sites to positively or negatively modulate receptor function.
• Biased agonism: Preferential activation of specific signaling pathways by a ligand at the same receptor.
• Efficacy: Maximum effect a ligand can produce at a receptor.
• Potency: Concentration or dose required to achieve a defined effect.
• Affinity (Kd/Ki): Strength of binding between ligand and receptor; lower values indicate stronger binding.
• Selectivity: Degree to which a compound preferentially targets one receptor over others.
• Off-target effects: Unintended interactions with other biological targets.

Pharmacokinetics (ADME)

• Absorption: Entry of a compound into systemic circulation (in vivo research context).
• Distribution: Dispersion of a compound through tissues and fluids.
• Metabolism: Biotransformation into metabolites via enzymatic processes (e.g., CYP450).
• Excretion: Removal of compounds and metabolites from the body.
• Half-life (t½): Time for concentration to decrease by half under specified conditions.
• Bioavailability: Fraction of administered compound reaching systemic circulation (research model–dependent).
• First-pass metabolism: Metabolic reduction in systemic availability during initial passage through organs (e.g., liver).
• Protein binding: Fraction of compound bound to proteins, affecting distribution and free concentration.

Safety and toxicology

• LD50: Approximate dose causing lethality in 50% of test subjects in a defined model; context-dependent.
• NOAEL: Highest dose at which no adverse effects are observed in a study.
• LOAEL: Lowest dose at which adverse effects are observed.
• Irritant: Substance causing reversible inflammation or discomfort upon exposure.
• Sensitizer: Substance that can induce allergic reactions after repeated exposure.
• Carcinogen: Substance associated with tumor formation in specific models.
• Mutagen: Agent that increases the frequency of genetic mutations.
• Teratogen: Agent that can disturb embryonic or fetal development in research models.
• Harm reduction (research context): Practices aimed at minimizing risk during laboratory handling and study.

Formulation, handling, and storage

Physical properties and solubility

• Solubility: Maximum amount of a substance that dissolves in a solvent under specified conditions.
• LogP/LogD: Partition coefficients indicating lipophilicity and distribution between phases.
• pKa: Acid dissociation constant reflecting strength of acidic/basic groups.
• Hygroscopic: Readily absorbs moisture from the air; requires controlled storage.
• Deliquescent: Absorbs moisture to the point of dissolving in it.
• Photolabile: Degraded or altered by exposure to light.
• Thermolabile: Degraded at elevated temperatures.
• Volatile: Tends to vaporize at room temperature; needs sealed storage.
• Viscosity: Measure of a fluid’s resistance to flow.

Preparation and dosing units (lab-only)

• Stock solution: Concentrated solution used to prepare working dilutions.
• Working solution: Final concentration solution used for an assay or experiment.
• Titration: Gradual addition of reagent to reach a reaction endpoint.
• Buffer: Solution resisting changes in pH upon addition of acid or base.
• Vehicle: Solvent or carrier for administering a compound in models.
• Excipient: Inert substance used to support formulation (research-only context).
• Micronization: Reduction of particle size to improve dispersion or dissolution.
• Lyophilization (freeze-drying): Removal of water via sublimation to enhance stability.

Storage and logistics

• Cold chain: Temperature-controlled storage and transport system for sensitive materials.
• Stability study: Evaluation of how a compound changes under defined conditions over time.
• Shelf life: Time period a compound remains within specification if stored correctly.
• Retained sample: Archived sample from a batch kept for future analysis or investigation.
• Quarantine: Controlled hold on materials pending inspection or test results.

Compliance, documentation, and risk management

Safety documentation

• SDS (safety data sheet): Standard document outlining hazards, handling, PPE, and emergency measures.
• GHS (globally harmonized system): International system for classifying and labeling chemicals.
• Hazard pictograms: Standardized icons indicating specific chemical hazards.
• PPE (personal protective equipment): Protective gear such as gloves and eye protection for lab work.
• Risk assessment: Structured evaluation of potential hazards and mitigation strategies.
• Exposure limit: Guideline value for airborne concentrations in occupational settings (varies by jurisdiction).

Regulatory concepts (general, non-advisory)

• Controlled substance (general): A compound regulated due to potential for misuse; subject to scheduling by jurisdiction.
• Listed chemical (general): Chemical monitored due to its role in synthesis of regulated substances.
• Scheduling (general): Classification framework determining restrictions and controls on specific compounds.
• Analog regulation (general): Laws in some jurisdictions that may apply controls to structurally related compounds.
• Import controls: Customs rules governing cross-border movement of chemicals; documentation required varies.
• Age verification: Process to confirm buyer eligibility in markets that require it for certain products.
• Restricted distribution: Internal policy limiting sales to qualified entities and lawful research uses.

Quality systems

• Specification: Defined acceptance criteria for identity, purity, and performance.
• Change control: Formal process to manage and document modifications affecting quality.
• Deviation: Departure from approved procedure requiring investigation.
• CAPA (corrective and preventive action): Measures to fix and prevent recurrence of quality issues.
• Traceability: Ability to track materials and data through all stages of receipt, testing, and distribution.
• Audit: Systematic examination of processes, records, and compliance status.

Data, measurement, and method validation

Statistics and measurement

• Repeatability: Precision under the same operating conditions over a short time.
• Reproducibility: Precision under changed conditions (different lab, analyst, equipment).
• Robustness: Method’s capacity to remain unaffected by small variations in parameters.
• Selectivity (analytical): Ability of a method to distinguish analyte from other components.
• Recovery: Percentage of analyte measured relative to the amount present in the sample.
• Spike (spiking): Adding a known amount of analyte to a sample to assess recovery and matrix effects.
• Standard addition: Calibration method that compensates for matrix effects by spiking.
• System suitability: Pre-run checks ensuring instrument and method performance meet criteria.

Documentation and records

• Raw data: Original records from instruments or observations before processing.
• Audit trail: Chronological record of changes made to data or documents.
• Metadata: Contextual information describing data sources, parameters, and conditions.
• Data integrity: Assurance that data are complete, consistent, and accurate throughout their lifecycle.
• Retrospective review: Post-hoc evaluation of data quality and compliance.

Synthesis, structure, and route design

Synthetic planning

• Precursor: A chemical used to synthesize another compound.
• Protecting group: Temporary modification to shield reactive sites during synthesis.
• Deprotection: Removal of protecting groups to restore functionality.
• Yield: Amount of product obtained relative to theoretical maximum.
• Atom economy: Efficiency metric considering the proportion of reactant atoms incorporated into the product.
• Byproduct: Secondary substances formed during reactions, sometimes requiring removal.
• Scalability: Feasibility of increasing synthesis from lab to larger quantities without compromising quality.

Structural description

• SMILES: Text representation of chemical structures using a standardized notation.
• InChI (International Chemical Identifier): Layered descriptor providing unique identification of chemical structures.
• Molecular weight: Sum of atomic weights; used in stoichiometry and dosing in lab contexts.
• Empirical formula: Simplest whole-number ratio of elements in a compound.
• Structure–activity relationship (SAR): Relationship between chemical structure and biological activity.
• QSAR: Quantitative modeling linking structural descriptors to measured activities.

How to use this glossary

• Find concepts quickly: Use section headings to locate terms by theme (analytical, pharmacology, compliance).
• Link across topics: Many terms interact—for example, salt form impacts solubility, which affects HPLC method setup.
• Stay within scope: Apply definitions in laboratory and compliance contexts; do not infer medical or legal advice.
• Request additions: If your team uses specialized terms not listed here, we can expand this glossary to fit your workflows.